ClinConnect ClinConnect Logo
Search / Trial NCT01945983

Early Use of Norepinephrine in Septic Shock Resuscitation

Launched by MAHIDOL UNIVERSITY · Sep 16, 2013

Trial Information

Current as of June 13, 2025

Completed

Keywords

Septic Shock Severe Sepsis Norepinephrine

ClinConnect Summary

We will include severe infection patient who had evidence of organ dysfunction and hypotension and randomize into 2 groups as following:

1. Control group. The patient will receive treatment according to septic shock guideline 2013, which start with intravenous fluid replacement until achieve target central venous pressure (CVP) or pulmonary capillary wedge pressure (PCWP) or other fluid responsive test goal. If the patient's mean arterial blood pressure still lower than 65 mmHg, then norepinephrine or dopamine will initiate to rise blood pressure. The patient will receive 5% dextrose water...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> or = 18 years old
  • Diagnosed severe sepsis or septic shock according to survival sepsis campaign 2013
  • Mean arterial pressure \< 65 mmHg
  • Exclusion Criteria:
  • Pregnancy
  • Severe underlying condition that unexpected to survive more than 48 hours
  • Severe peripheral vascular disease
  • Patient who required major surgery within 24 hours

About Mahidol University

Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.

Locations

Bangkok, , Thailand

Patients applied

0 patients applied

Trial Officials

Chairat Permpikul, MD

Principal Investigator

Mahidol University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials